The Bonnie J. Addario Lung Cancer Foundation
The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

Bonnie Addario in UCSF Lab
 

Erbitux Plus Chemo Improves Lung Cancer Outcomes

Chemo drugs1.jpgThe long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks when combined with chemotherapy.

This entry was posted on Saturday, May 31st, 2008 at 8:56 pm and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

« Erbitux adds 5 weeks to lung cancer survival
Blood test may identify lung cancer in early stages »

Leave a Reply